Dongkook Pharmaceutical Decides to Acquire Gangnam Land and Buildings Worth 82.7 Billion KRW

[Asia Economy Reporter Yoo Byung-don] Dongkook Pharmaceutical announced on the 28th that its subsidiary, Multi-Asset Specialized Investment Private Real Estate No. 7 Investment Limited Company, has decided to acquire land and buildings located at 71-18, 19 Cheongdam-dong, Gangnam-gu, Seoul, valued at 82.7 billion KRW.

This amount corresponds to 12.47% of Dongkook Pharmaceutical's total assets, and the acquisition date is set for January 4 of next year.

The company explained the purpose of the acquisition as "the need for a new office building due to the aging of the existing headquarters and an increase in personnel."

This content was produced with the assistance of AI translation services.